Unusual volume stocks are being observed in Wednesday's session.
By Mill Chart
Last update: May 1, 2024
The trading volume of these stocks is deviating from the norm in today's session.
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| CYCC | 26.42% | CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC) has an unusual volume of 4.6M shares. Leading to a price increase of 26.42%. With an average daily volume of 572.02K over the past 50 days, today's volume is 704.0% above the average, indicating a potential shift in market sentiment. A press release (Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules) was released yesterday. |
| CSSE | 14.5% | The stock of CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) has caught attention with a significant volume of 6.88M shares today. Shares in NASDAQ:CSSE are on the rise, with a gain of 14.5% observed in today's trading session. Compared to the average daily volume of the past 50 days, the current volume is 22.39% above, suggesting an unusual level of trading activity. |
| CSSEL | 35.0% | Today, CHICKEN SOUP FOR THE SOUL-26 (NASDAQ:CSSEL) stands out with a high volume of 2.14M shares. The share price of NASDAQ:CSSEL increased by 35.0% today, reflecting positive market movement. The current trading volume is 968.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. |
| BMRA | 7.21% | 329.77K shares of BIOMERICA INC (NASDAQ:BMRA) exchanged hands today. The market is favoring NASDAQ:BMRA today, as its share price records a notable increase of 7.21%. The average volume measured over 50 days is 228.0K, so this is 44.64% above the average volume. |
| DCPH | 0.2% | DECIPHERA PHARMACEUTICALS IN (NASDAQ:DCPH) has an unusual volume of 2.31M shares. NASDAQ:DCPH is experiencing an advancement of 0.2% in its share price today. The average volume measured over 50 days is 1.59M, so this is 45.34% above the average volume. The company's earnings where released Yesterday. A press release (ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals) was released yesterday. |
| ANVS | 12.84% | ANNOVIS BIO (NYSE:ANVS) has an unusual volume of 770.57K shares today. The share price of NYSE:ANVS increased by 12.84% today, reflecting positive market movement. This volume is 60.04% above the average 50 day volume. |
| BRKHW | 0.0% | So far 290.35K shares of BURTECH ACQUISITION -CW23 (NASDAQ:BRKHW) have traded in today's session. With an average daily volume of 109.68K over the past 50 days, today's volume is 165.0% above the average, indicating a potential shift in market sentiment. |
| WGS | 19.92% | The trading volume of GENEDX HOLDINGS CORP (NASDAQ:WGS) today is 1.07M shares, which is considered unusual. The share price increased by 19.92%. The average daily volume over 50 days is 348.81K, so this is 207.0% above the average volume. A press release (GeneDx Reports First Quarter 2024 Financial Results and Business Highlights) was released two days ago. |
| NWGL | -4.27% | With 150.51K shares traded so far, NATURE WOOD GROUP LTD-SP ADR (NASDAQ:NWGL) is experiencing an unusual level of activity today. The share price decreased by 4.27%. The average daily volume over the past 50 days is 103.78K. Hence, the current volume is 45.03% above the average volume, indicating a deviation from the usual trading pattern. |
| GV | -26.92% | Today, VISIONARY HOLDINGS INC (NASDAQ:GV) stands out with a high volume of 664.72K shares. The price decline of 26.92% reflects a downward movement in NASDAQ:GV shares. Compared to the average daily volume of the past 50 days, the current volume is 434.0% above, suggesting an unusual level of trading activity. |
Our unusual volume stocks screener will show you the full list.
BIOMERICA INC
NASDAQ:BMRA (5/17/2024, 7:00:02 PM)
After market: 0.632 -0.03 (-5.01%)0.6653
+0.06 (+9.6%)
BMRA News
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the initiation of a pilot program for its inFoods® IBS product with a large 1,100-member physician group. This pilot launch will commence in June 2024.
17 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.The trading volume of these stocks is deviating from the norm in today's session.
18 days ago - ChartmillIn today's session, these stocks are experiencing unusual volume.Discover the stocks with unexpected trading volume in today's session on the US markets.
Dubai Healthcare Authority Granted Insurance Reimbursement for Biomerica’s EZ Detect™ Colon Disease Screening Test EZ Detect™ is a simple FDA cleared...
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly...
a month ago - InvestorPlaceBMRA Stock Earnings: Biomerica Reported Results for Q3 2024Biomerica just reported results for the third quarter of 2024.
a month ago - BusinessInsiderBMRA Stock Earnings: Biomerica Reported Results for Q3 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biomerica (NASDAQ:BMRA) just reported results for the third quarter of 2024.Bio...
IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended February 29, 2024.
Collaborators at the University of Michigan will present new Data on InFoods® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE,...
3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and...
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of...
